187 related articles for article (PubMed ID: 37510310)
1. High Expression of
Wang Y; Zhao Y; Zhang Z; Zhang J; Xu Q; Zhou X; Mao L
Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510310
[No Abstract] [Full Text] [Related]
2. Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma.
Mou Y; Zhang L; Liu Z; Song X
BMC Cancer; 2022 Feb; 22(1):215. PubMed ID: 35227235
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
Hu Y; Tu Z; Lei K; Huang K; Zhu X
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238
[TBL] [Abstract][Full Text] [Related]
4. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
Tian QS; Zhang Q; Huang W
Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
[TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma.
Chen Z; Wu T; Yan Z; Zhang M
Front Cell Dev Biol; 2021; 9():652599. PubMed ID: 34249910
[TBL] [Abstract][Full Text] [Related]
6. High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity.
Liu S; Wang Y; Miao C; Xing Q; Wang Z
Cancer Cell Int; 2021 Mar; 21(1):140. PubMed ID: 33648519
[TBL] [Abstract][Full Text] [Related]
7. A Ferroptosis-Related Gene Prognostic Index to Predict Temozolomide Sensitivity and Immune Checkpoint Inhibitor Response for Glioma.
Cai Y; Liang X; Zhan Z; Zeng Y; Lin J; Xu A; Xue S; Xu W; Chai P; Mao Y; Song Z; Han L; Xiao J; Song Y; Zhang X
Front Cell Dev Biol; 2021; 9():812422. PubMed ID: 35174170
[No Abstract] [Full Text] [Related]
8. Remarkable immune and clinical value of novel ferroptosis-related genes in glioma.
Gao X; Zhao J; Jia L; Zhang Q
Sci Rep; 2022 Jul; 12(1):12854. PubMed ID: 35896732
[TBL] [Abstract][Full Text] [Related]
9. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
10. Ferroptosis-related NFE2L2 and NOX4 Genes are Potential Risk Prognostic Biomarkers and Correlated with Immunogenic Features in Glioma.
Lin L; Li X; Zhu S; Long Q; Hu Y; Zhang L; Liu Z; Li B; Li X
Cell Biochem Biophys; 2023 Mar; 81(1):7-17. PubMed ID: 36627482
[TBL] [Abstract][Full Text] [Related]
11. IRF2-ferroptosis related gene is associated with prognosis and EMT in gliomas.
Tong S; Ye L; Xu Y; Sun Q; Gao L; Cai J; Ye Z; Tian D; Chen Q
Transl Oncol; 2022 Dec; 26():101544. PubMed ID: 36156371
[TBL] [Abstract][Full Text] [Related]
12. ABCD3 is a prognostic biomarker for glioma and associated with immune infiltration: A study based on oncolysis of gliomas.
Li J; Zhang Y; Qu Z; Ding R; Yin X
Front Cell Infect Microbiol; 2022; 12():956801. PubMed ID: 35959373
[TBL] [Abstract][Full Text] [Related]
13. Research into the characteristic molecules significantly affecting liver cancer immunotherapy.
Chen J; Jin H; Zhou H; Hei X; Liu K
Front Immunol; 2023; 14():1029427. PubMed ID: 36860864
[TBL] [Abstract][Full Text] [Related]
14. Matrix Remodeling-Associated Protein 8 as a Novel Indicator Contributing to Glioma Immune Response by Regulating Ferroptosis.
Xu Z; Chen X; Song L; Yuan F; Yan Y
Front Immunol; 2022; 13():834595. PubMed ID: 35281049
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of transferrin receptor protein 1 for predicting prognosis and immune infiltration in lower grade glioma.
Wu H; He H; Huang J; Wang C; Dong Y; Lin R; Cheng Z; Qiu Q; Hong L
Front Mol Neurosci; 2022; 15():972308. PubMed ID: 36483569
[TBL] [Abstract][Full Text] [Related]
16. Expression and Prognostic Value of ARID5A and its Correlation With Tumor-Infiltrating Immune Cells in Glioma.
Zhou Q; Zhou J; Fan J
Front Oncol; 2021; 11():638803. PubMed ID: 34094918
[TBL] [Abstract][Full Text] [Related]
17.
Ge X; Xu M; Cheng T; Hu N; Sun P; Lu B; Wang Z; Li J
Front Immunol; 2022; 13():974346. PubMed ID: 36275718
[TBL] [Abstract][Full Text] [Related]
18. MELK is a prognostic biomarker and correlated with immune infiltration in glioma.
Yang H; Zhou H; Wang G; Tian L; Li H; Zhang Y; Xue X
Front Neurol; 2022; 13():977180. PubMed ID: 36353126
[TBL] [Abstract][Full Text] [Related]
19. A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients.
Xiang Z; Chen X; Lv Q; Peng X
Front Genet; 2021; 12():697819. PubMed ID: 34408772
[TBL] [Abstract][Full Text] [Related]
20. A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy.
Zeng Z; Hu C; Ruan W; Zhang J; Lei S; Yang Y; Peng P; Pan F; Chen T
Front Immunol; 2022; 13():1001381. PubMed ID: 36159801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
